Humana Inc (HUM) Shares Bought by Nissay Asset Management Corp Japan ADV

Nissay Asset Management Corp Japan ADV raised its stake in shares of Humana Inc (NYSE:HUM) by 1.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,234 shares of the insurance provider’s stock after purchasing an additional 329 shares during the quarter. Nissay Asset Management Corp Japan ADV’s holdings in Humana were worth $5,834,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently made changes to their positions in the company. Sun Life Financial INC lifted its position in Humana by 120.7% during the second quarter. Sun Life Financial INC now owns 373 shares of the insurance provider’s stock valued at $111,000 after purchasing an additional 204 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. lifted its position in Humana by 2,984.6% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock valued at $119,000 after purchasing an additional 388 shares during the last quarter. Patriot Financial Group Insurance Agency LLC lifted its position in Humana by 64.6% during the third quarter. Patriot Financial Group Insurance Agency LLC now owns 512 shares of the insurance provider’s stock valued at $173,000 after purchasing an additional 201 shares during the last quarter. Palo Capital Inc. bought a new stake in Humana during the third quarter valued at approximately $178,000. Finally, NuWave Investment Management LLC bought a new stake in Humana during the second quarter valued at approximately $198,000. Institutional investors and hedge funds own 92.57% of the company’s stock.

Shares of HUM opened at $320.41 on Thursday. The company has a market capitalization of $44.57 billion, a PE ratio of 27.36, a price-to-earnings-growth ratio of 1.61 and a beta of 0.97. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.43 and a quick ratio of 1.43. Humana Inc has a fifty-two week low of $231.90 and a fifty-two week high of $341.30.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, August 1st. The insurance provider reported $3.96 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.79 by $0.17. The firm had revenue of $14.26 billion during the quarter, compared to analyst estimates of $14.16 billion. Humana had a net margin of 2.48% and a return on equity of 17.43%. During the same period in the previous year, the business posted $3.49 EPS. Equities research analysts expect that Humana Inc will post 14.18 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, October 26th. Investors of record on Friday, September 28th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.62%. The ex-dividend date was Thursday, September 27th. Humana’s payout ratio is 17.08%.

In related news, SVP Cynthia H. Zipperle sold 4,886 shares of Humana stock in a transaction on Friday, August 3rd. The shares were sold at an average price of $321.89, for a total value of $1,572,754.54. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Roy A. Beveridge sold 14,306 shares of Humana stock in a transaction on Monday, August 6th. The stock was sold at an average price of $324.25, for a total transaction of $4,638,720.50. Following the completion of the transaction, the insider now directly owns 15,274 shares in the company, valued at $4,952,594.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 40,284 shares of company stock worth $13,147,715. 0.60% of the stock is owned by insiders.

HUM has been the subject of several research analyst reports. ValuEngine upgraded shares of Humana from a “hold” rating to a “buy” rating in a research report on Wednesday, July 4th. Piper Jaffray Companies lifted their target price on shares of Humana from $326.00 to $350.00 and gave the company an “overweight” rating in a research report on Friday, July 6th. Morgan Stanley initiated coverage on shares of Humana in a research report on Thursday, July 12th. They set an “overweight” rating and a $362.00 target price for the company. Royal Bank of Canada reiterated a “hold” rating and set a $318.00 target price on shares of Humana in a research report on Thursday, August 2nd. Finally, Jefferies Financial Group lifted their target price on shares of Humana from $356.00 to $372.00 and gave the company a “buy” rating in a research report on Thursday, August 2nd. Seven investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $339.79.

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Featured Article: What is a stock split?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply